Fig. 1From: Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastasesKaplan-Meier survival curves for recurrence-free survival. a RFS according to the KRAS mutational status in patients with colorectal liver metastases (CLRM). Subgroup analyses for RFS in patients with (b) metachronous and (c) synchronous metastases. RFS, recurrence-free survivalBack to article page